Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer

Background and study aims: The HER2 status of small endoscopic biopsies is important for predicting the eligibility of patients with metastatic HER2-positive gastric cancer or gastro-esophageal junction (GEJ) cancer for anti-HER2 therapy approved by the U.S. Food and Drug Administration. The aim of...

Full description

Bibliographic Details
Main Authors: Irene Gullo, Federica Grillo, Luca Molinaro, Matteo Fassan, Annalisa De Silvestri, Carmine Tinelli, Massimo Rugge, Roberto Fiocca, Luca Mastracci
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2015-02-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1391359

Similar Items